IndraLab

Statements

Everolimus inhibits mutated BAP1. 1 / 1

| 1

reach

"PBRM1 mutations were also associated with increased PFS while BAP1 mutations were associated with a decreased PFS in patients treated with first-line everolimus [XREF_BIBR]."

31313716

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Everolimus inhibits mutated BAP1. 1 / 1

INDRA sources:

Databases

Reading